http://www.bioprocessintl.com/wp-content/uploads/2014/12/Facility-Winner_Gallus_GE.jpg
Our partnership with Gallus BioPharmaceuticals to build an
advanced contract manufacturing facility has much to show for the nine months it
has existed. The latest achievement is the BioProcess International (BPI)
industry “Excellence in Facility Design or Retrofit” award. In an article for Biospace, Parrish Galliher of GE
Healthcare Life Sciences spoke about this award-winning facility, “We are honoured to receive this award
alongside Gallus, and it is a pleasure to receive such great recognition from
our peers. . . The winning facility, built around our FlexFactory
biomanufacturing platform, is a clear example of how single-use technologies
are now playing a major role in supporting the cost-effective development of
biotherapeutics.”
GE Healthcare was also nominated for BPI industry awards in
three other categories. Our general manager of Enterprise Solutions and
Commercial BioProcess, Olivier Loeillot, was nominated for “Excellence in
Leadership” and a “Best Technology Application (Upstream)” nomination went to
our Xcellerex XDR-50 MO Fermentor. GE Healthcare’s partnership with Promosome
LLC also was nominated for “Most Effective Licensing or Comarketing Agreement”.
For more information on these nominations, see http://www.genewsroom.com/press-releases/ge-healthcare-life-sciences-wins-prestigious-bioprocessing-industry-award-278932
and http://www.biospace.com/News/gallus-biopharmaceuticals-llc-and-ge-healthcare/351731.
No comments:
Post a Comment